Anika Therapeutics (ANIK) Inventory Average (2016 - 2025)
Historic Inventory Average for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to $16.6 million.
- Anika Therapeutics' Inventory Average fell 6354.71% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 6354.71%. This contributed to the annual value of $24.1 million for FY2024, which is 2485.63% down from last year.
- As of Q3 2025, Anika Therapeutics' Inventory Average stood at $16.6 million, which was down 6354.71% from $19.1 million recorded in Q2 2025.
- Anika Therapeutics' Inventory Average's 5-year high stood at $50.4 million during Q2 2024, with a 5-year trough of $16.6 million in Q3 2025.
- Moreover, its 5-year median value for Inventory Average was $36.9 million (2024), whereas its average is $36.3 million.
- Per our database at Business Quant, Anika Therapeutics' Inventory Average soared by 3741.75% in 2021 and then crashed by 6354.71% in 2025.
- Quarter analysis of 5 years shows Anika Therapeutics' Inventory Average stood at $35.5 million in 2021, then grew by 8.41% to $38.5 million in 2022, then fell by 11.49% to $34.1 million in 2023, then dropped by 6.92% to $31.7 million in 2024, then plummeted by 47.66% to $16.6 million in 2025.
- Its Inventory Average stands at $16.6 million for Q3 2025, versus $19.1 million for Q2 2025 and $22.6 million for Q1 2025.